Leukemia Home > Bone Marrow Damage Due to Treanda

Although Treanda® (bendamustine) can be an effective medication for treating certain types of cancer, it is not appropriate for some people. For example, if you have anemia or get infections easily, make sure to talk to your healthcare provider about the potential risks.
Bone marrow damage can occur with Treanda. As with other chemotherapy drugs, Treanda reduces the activity of bone marrow and decreases the production of red blood cells, white blood cells, and platelets. This increases your risk for problems like anemia, infections, and bleeding.
Your healthcare provider will monitor your blood cell counts frequently during treatment, and may decrease your dosage or delay treatment if your blood cell counts become too low.
(Click Treanda Warnings and Precautions for more details on important safety precautions to be aware of before starting treatment with this medication. This article also discusses who should not use Treanda.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.